← All indications
Thrombosis
Formation and development of a thrombus or blood clot in BLOOD VESSELS.
Subtype terms (4)
More specific conditions that are subtypes of Thrombosis in the MeSH hierarchy.
- Coronary Thrombosis
5 drugs (3 approved, 2 experimental)
- Livedoid Vasculopathy
39 drugs (34 approved, 5 experimental)
- Thromboinflammation
- Venous Thrombosis
75 drugs (47 approved, 28 experimental)
Drugs by status
Approved for this indication (14)
Phase 4 trials (33)
- edoxaban
- heparin
- sintrom
- dabigatran
- epoetin
- desirudin
- empagliflozin
- rosuvastatin
- fibrinogen (human)
- warfarin
- human factor ix complex (prothrombin complex concentrate)
- fondaparinux sodium
- atorvastatin
- ticagrelor
- prasugrel
- acetylsalicylic acid
- sotagliflozin
- alteplase
- pantoprazole
- triflusal
- enoxaparin
- phenprocoumon
- alprostadil
- rivaroxaban
- cilostazol
- apixaban
- clopidogrel
- blood plasma
- thrombin (human coagulation factor iia)
- sodium chloride
- +3 more
Phase 3 trials (29)
- simvastatin
- alfimeprase
- acetylcysteine
- sorafenib
- busulfan
- clevidipine
- edaravone
- conjugated equine estrogens
- progesterone
- tenecteplase
- Noiiglutide
- idraparinux
- colchicine
- valsartan
- propranolol
- streptokinase
- reteplase
- cyclophosphamide
- tecarfarin
- urokinase
- medroxyprogesterone
- tranexamic acid
- antithrombin iii (human)
- cytarabine
- omeprazole
- estrogen
- phytonadione
- dexamethasone
- shr-2004
Phase 2 trials (31)
- methylprednisolone
- axitinib
- atezolizumab
- apolipoprotein
- bms 986141
- defibrotide
- prednisone
- ds-1040b
- enalapril
- fluindione
- hydralazine
- pembrolizumab
- labetalol
- lenvatinib
- lepirudin
- levamisole
- lipotecan
- menaquinone
- recombinant human adenovirus type 5
- immune globulin (human)
- cyclosporine
- bevacizumab
- aminocaproic acid
- xisomab 3g3
- camrelizumab
- Abelacimab
- e-we thrombin
- 99mtc-annexin-v-128
- garadacimab
- pegcetacoplan
- +1 more
Phase 1 trials (18)
Other trials (23)
- Poloxalene
- butylphthalide
- Lumbricus rubellus
- doxorubicin
- ethiodized oil
- tobacco
- platelet rich fibrin
- rifaximin
- technetium tc-99m sulfur colloid kit
- vitamin k
- dexmedetomidine
- 125-iodine
- hirudin
- thienoyridine
- sodium bicarbonate
- diphenadione sodium
- ethyl biscoumacetate
- salmon
- ubiquinone
- tislelizumab
- Yellowstripe Scad
- batroxobin
- staphylokinase
Organizations
Organization Involved with Phase 4 Indications (160)
- DuPont
- Canyon Pharmaceuticals
- Daiichi Sankyo
- Bristol-Myers Squibb
- Roche
- Aspen Pharmaceuticals
- AstraZeneca
- Aventis
- Pfizer
- Sanofi
- Sanofi-Synthelabo
- Bayer
- GlaxoSmithKline
- Hamad Medical Corporation
- Les Laboratoires des Médicaments Stériles
- Medical Compression Systems
- Accumetrics, Inc.
- Boehringer Ingelheim
- CardioVascular Research Foundation, Korea
- Danish Heart Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Heart, Lung, and Blood Institute (NHLBI)
- Fundacion Clinic per a la Recerca Biomédica
- Huazhong University of Science and Technology
- Aarhus University
- Rockefeller University
- University of Manitoba
- University of Pittsburgh
- Ain Shams University
- Allegiance Health
- +130 more
Organization Involved with Phase 3 Indications (147)
- Genentech
- Arca Biopharma, Inc.
- Armetheon Inc
- Biocad
- Boston Scientific Corporation
- Chiesi
- ECRI bv
- GWT-TUD GmbH
- Hamilton Health Sciences Corporation
- Menarini Group
- Nihon Pharmaceutical Co., Ltd
- Ortho Biotech, Inc.
- German Research Foundation
- Swiss National Science Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute on Aging (NIA)
- Università degli Studi dell'Insubria
- Academia Sinica, Taiwan
- Academic and Community Cancer Research United
- Maastricht University
- Central South University
- Anhui Medical University
- Boston University
- CAMC Health System
- Canadian Critical Care Trials Group
- Canadian Heart Research Centre
- +117 more
Organization Involved with Phase 2 Indications (47)
- CSL Behring
- Grifols
- Novartis
- Danisco
- Taiwan Liposome Company
- vTv Therapeutics
- Agen Biomedical
- Aronora, Inc.
- Fundación Pública Andaluza
- Alexandria University
- Temple University
- D'Annunzio University of Chieti–Pescara
- Henry Ford Health System
- Health Decisions
- Medical College of Wisconsin
- New York University
- Sichuan University
- Universidad Autonoma de Nuevo Leon
- University of Michigan
- University of Seville
- Yale University
- University of Vermont
- Cardiff University
- Peking University
- University of British Columbia
- University of California, Irvine
- University of Cambridge
- Uppsala University
- Celerion
- Medical University of Vienna
- +17 more
Organization Involved with Phase 1 Indications (22)
- AdvanceCor GmbH
- Merck
- Archemix Corp.
- Diakron Pharmaceuticals
- Hengrui Therapeutics, Inc.
- Piramal
- Translational Sciences, Inc.
- University of Pennsylvania
- Baylor University
- Ohio State University
- Thomas Jefferson University
- University of Southern California
- Tsinghua University
- Medpace, Inc.
- Pennsylvania State University
- ABX-CRO
- Kinesis Pharma
- Procorde GmbH
- Ghent University
- Shijiazhuang Pharma Group (CSPC)
- Cereno Scientific AB
- Band Therapeutics
Organization Involved with Other Experimental Indications (61)
- Abbott
- Rhone-Poulenc Rorer
- Prairie Education and Research Cooperative
- Marshfield Clinic Research Foundation
- Wu Jieping Medical Foundation
- National Center for Research Resources (NCRR)
- United States Army
- William Beaumont Hospitals
- Blood Center of Wisconsin
- Cedars-Sinai Medical Center
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- University of Washington
- Guangzhou Medical University
- Hospital do Servidor Publico Estadual
- Hawler Medical University
- Kosuyolu Heart Hospital
- Newton-Wellesley Hospital
- NHS Lothian
- University of Edinburgh
- University of Limerick
- University of South Florida
- University of Tennessee
- University of Athens
- Xuzhou Medical University
- Assiut University
- Chongqing Medical University
- Daegu Catholic University
- Institute of Liver and Biliary Sciences, India
- Wenzhou Medical University
- King Abdullah Medical City
- +31 more